We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

86 hedge funds and large institutions have $61.6M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $4.23M | Put options by funds: $1.76M

82% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 17

58% more capital invested

Capital invested by funds: $39M → $61.6M (+$22.6M)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

1% less funds holding

Funds holding: 87 → 86 (-1)

Holders
86
Holders Change
-1
Holders Change %
-1.15%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
17
Closed
19
Calls
$4.23M
Puts
$1.76M
Net Calls
+$2.47M
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.52M
2
Millennium Management
Millennium Management
New York
+$1.45M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.31M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.01M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$966K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.19M
2
SSA
Schonfeld Strategic Advisors
New York
-$1.12M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.1M
4
Group One Trading
Group One Trading
Illinois
-$1.02M
5
Simplex Trading
Simplex Trading
Illinois
-$814K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
26
HRT Financial
New York
$608K +$491K +140,909 New
Citigroup
27
Citigroup
New York
$558K +$150K +43,117 +50%
LFAS
28
Level Four Advisory Services
Texas
$545K – – –
Northern Trust
29
Northern Trust
Illinois
$542K -$38 -11 -0%
Squarepoint
30
Squarepoint
New York
$454K +$310K +88,938 +548%
FCA
31
FinTrust Capital Advisors
South Carolina
$435K – – –
CM
32
Caption Management
Oklahoma
$421K +$340K +97,568 New
DA
33
Denali Advisors
California
$372K -$124K -35,700 -29%
FSA
34
Franklin Street Advisors
North Carolina
$360K – – –
BC
35
Birchview Capital
Vermont
$346K – – –
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$335K +$3.01K +865 +1%
CRC
37
Curi RMB Capital
Illinois
$306K +$247K +70,795 New
Fidelity Investments
38
Fidelity Investments
Massachusetts
$259K -$4.79K -1,374 -2%
JP Morgan Chase
39
JP Morgan Chase
New York
$236K +$190K +54,384 +21,754%
BHCM
40
Brevan Howard Capital Management
Jersey
$205K +$166K +47,545 New
BPA
41
Beacon Pointe Advisors
California
$189K – – –
CFD
42
Creative Financial Designs
Indiana
$175K +$18.2K +5,225 +15%
Ameriprise
43
Ameriprise
Minnesota
$153K – – –
Envestnet Asset Management
44
Envestnet Asset Management
Illinois
$153K +$27K +7,740 +28%
CL
45
Choreo LLC
Illinois
$152K – – –
American Century Companies
46
American Century Companies
Missouri
$150K +$63.7K +18,267 +112%
RJFSA
47
Raymond James Financial Services Advisors
Florida
$136K -$8.04K -2,308 -7%
Wells Fargo
48
Wells Fargo
California
$134K +$29.6K +8,507 +38%
Capstone Investment Advisors
49
Capstone Investment Advisors
New York
$118K +$7.84K +2,250 +9%
YIH
50
Y-Intercept (HK)
Hong Kong
$115K +$19.5K +5,582 +26%
1
2
3 4 5

GTHX Hedge Fund Activity: Q1 2024 in Review

86 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2024, worth a combined $61.6M — up 58% from $39M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of GTHX and 18 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 31 added.

The largest buyer was Goldman Sachs, adding an estimated $1.52M. The largest seller was Susquehanna International Group, cutting an estimated $2.19M.

  • 86 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2024, down from 87 in Q4 2023.
  • Funds reported $61.6M of G1 Therapeutics, Inc. Common Stock stock for Q1 2024, up 58% quarter-over-quarter.
  • 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of -1 holder.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2024 was Goldman Sachs, an estimated $1.52M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2024 was Susquehanna International Group, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2024.